View ValuationIBU-tec advanced materials 향후 성장Future 기준 점검 5/6IBU-tec advanced materials (는) 각각 연간 74.5% 및 26.5% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 74.8% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 4.7% 로 예상됩니다.핵심 정보74.5%이익 성장률74.80%EPS 성장률Chemicals 이익 성장43.5%매출 성장률26.5%향후 자기자본이익률4.70%애널리스트 커버리지Low마지막 업데이트14 Apr 2026최근 향후 성장 업데이트Price Target Changed • May 20Price target increased by 238% to €25.00Up from €7.40, the current price target is provided by 1 analyst. New target price is 60% above last closing price of €15.65. Stock is up 123% over the past year. The company is forecast to post a net loss per share of €0.44 compared to earnings per share of €0.0012 last year.공시 • Apr 16Ibu-Tec Advanced Materials Ag Provides Revenue Guidance for 2025Ibu-Tec Advanced Materials Ag provided Revenue Guidance for 2025. For the period, the company expected revenue EUR 43 million to EUR 45 million after consolidated revenues of around EUR 50.6 million in the past financial year according to preliminary unaudited figures.Price Target Changed • Dec 30Price target decreased by 38% to €7.40Down from €12.00, the current price target is provided by 1 analyst. New target price is 13% above last closing price of €6.52. Stock is down 64% over the past year. The company posted a net loss per share of €0.52 last year.Price Target Changed • Nov 16Price target decreased to €58.00Down from €64.50, the current price target is provided by 1 analyst. New target price is 119% above last closing price of €26.50. Stock is down 38% over the past year. The company is forecast to post earnings per share of €0.13 next year compared to a net loss per share of €0.049 last year.Price Target Changed • Apr 27Price target increased to €64.50Up from €38.73, the current price target is provided by 1 analyst. New target price is 88% above last closing price of €34.35. Stock is down 17% over the past year. The company is forecast to post earnings per share of €0.16 for next year compared to €0.25 last year.Price Target Changed • Jan 27Price target raised to €28.07Up from €18.10, the current price target is an average from 3 analysts. The new target price is 20% below the current share price of €35.20. As of last close, the stock is up 135% over the past year.모든 업데이트 보기Recent updatesPrice Target Changed • May 20Price target increased by 238% to €25.00Up from €7.40, the current price target is provided by 1 analyst. New target price is 60% above last closing price of €15.65. Stock is up 123% over the past year. The company is forecast to post a net loss per share of €0.44 compared to earnings per share of €0.0012 last year.공시 • Apr 09+ 1 more updateIBU-tec advanced materials AG announces Annual dividend, payable on May 22, 2026IBU-tec advanced materials AG announced Annual dividend of EUR 0.1200 per share payable on May 22, 2026, ex-date on May 20, 2026 and record date on May 21, 2026.공시 • Mar 30+ 1 more updateIBU-tec advanced materials AG to Report Fiscal Year 2025 Results on Apr 08, 2026IBU-tec advanced materials AG announced that they will report fiscal year 2025 results at 12:00 PM, Central European Standard Time on Apr 08, 2026공시 • Jun 24IBU-tec advanced materials AG to Report First Half, 2025 Results on Aug 27, 2025IBU-tec advanced materials AG announced that they will report first half, 2025 results on Aug 27, 2025공시 • Apr 17IBU-tec advanced materials AG, Annual General Meeting, May 26, 2025IBU-tec advanced materials AG, Annual General Meeting, May 26, 2025, at 10:00 W. Europe Standard Time.공시 • Apr 16Ibu-Tec Advanced Materials Ag Provides Revenue Guidance for 2025Ibu-Tec Advanced Materials Ag provided Revenue Guidance for 2025. For the period, the company expected revenue EUR 43 million to EUR 45 million after consolidated revenues of around EUR 50.6 million in the past financial year according to preliminary unaudited figures.공시 • Jan 08IBU-tec advanced materials AG to Report Fiscal Year 2024 Results on Mar 20, 2025IBU-tec advanced materials AG announced that they will report fiscal year 2024 results at 12:00 PM, Central European Standard Time on Mar 20, 2025Price Target Changed • Dec 30Price target decreased by 38% to €7.40Down from €12.00, the current price target is provided by 1 analyst. New target price is 13% above last closing price of €6.52. Stock is down 64% over the past year. The company posted a net loss per share of €0.52 last year.Reported Earnings • Sep 01First half 2024 earnings released: €0.66 loss per share (vs €0.078 profit in 1H 2023)First half 2024 results: €0.66 loss per share (down from €0.078 profit in 1H 2023). Revenue: €25.3m (down 1.1% from 1H 2023). Net loss: €3.15m (down €3.53m from profit in 1H 2023). Revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 25 percentage points per year, which is a significant difference in performance.공시 • Aug 29IBU-tec advanced materials AG to Report First Half, 2024 Results on Aug 27, 2024IBU-tec advanced materials AG announced that they will report first half, 2024 results on Aug 27, 2024공시 • Mar 22IBU-tec advanced materials AG, Annual General Meeting, Apr 30, 2024IBU-tec advanced materials AG, Annual General Meeting, Apr 30, 2024.Valuation Update With 7 Day Price Move • Mar 22Investor sentiment improves as stock rises 22%After last week's 22% share price gain to €11.46, the stock trades at a trailing P/E ratio of 51.8x. Average forward P/E is 18x in the Chemicals industry in Germany. Total loss to shareholders of 74% over the past three years.공시 • Mar 21IBU-tec advanced materials AG to Report Fiscal Year 2023 Results on Mar 21, 2024IBU-tec advanced materials AG announced that they will report fiscal year 2023 results on Mar 21, 2024New Risk • Mar 12New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (15% average weekly change). High level of non-cash earnings (22% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Market cap is less than US$100m (€47.5m market cap, or US$51.9m).Valuation Update With 7 Day Price Move • Jan 29Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €15.98, the stock trades at a trailing P/E ratio of 65.2x. Average forward P/E is 13x in the Chemicals industry in Germany. Total loss to shareholders of 56% over the past three years.Valuation Update With 7 Day Price Move • Jan 13Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to €13.68, the stock trades at a trailing P/E ratio of 56.9x. Average forward P/E is 13x in the Chemicals industry in Germany. Total loss to shareholders of 44% over the past three years.New Risk • Dec 09New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €90.7m (US$97.7m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (14% average weekly change). High level of non-cash earnings (22% accrual ratio). Minor Risk Market cap is less than US$100m (€90.7m market cap, or US$97.7m).Valuation Update With 7 Day Price Move • Oct 20Investor sentiment deteriorates as stock falls 21%After last week's 21% share price decline to €18.00, the stock trades at a forward P/E ratio of 62x. Average forward P/E is 15x in the Chemicals industry in Germany. Total returns to shareholders of 42% over the past three years.Reported Earnings • Aug 30First half 2023 earnings released: EPS: €0.078 (vs €0.10 in 1H 2022)First half 2023 results: EPS: €0.078 (down from €0.10 in 1H 2022). Revenue: €25.5m (down 14% from 1H 2022). Net income: €372.8k (down 24% from 1H 2022). Profit margin: 1.5% (down from 1.7% in 1H 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 30% p.a. on average during the next 3 years, compared to a 2.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 28% per year, which means it is tracking significantly ahead of earnings growth.New Risk • Aug 28New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 22% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (22% accrual ratio). Minor Risk Share price has been volatile over the past 3 months (8.0% average weekly change).Upcoming Dividend • Apr 20Upcoming dividend of €0.04 per share at 0.1% yieldEligible shareholders must have bought the stock before 27 April 2023. Payment date: 02 May 2023. Trailing yield: 0.1%. Lower than top quartile of German dividend payers (4.7%). Lower than average of industry peers (5.3%).Reported Earnings • Mar 27Full year 2022 earnings releasedFull year 2022 results: Revenue: €56.0m (up 26% from FY 2021). Net income: €1.28m (up €1.52m from FY 2021). Profit margin: 2.3% (up from net loss in FY 2021). The move to profitability was driven by higher revenue. Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 1.9% growth forecast for the Chemicals industry in Germany.Price Target Changed • Nov 16Price target decreased to €58.00Down from €64.50, the current price target is provided by 1 analyst. New target price is 119% above last closing price of €26.50. Stock is down 38% over the past year. The company is forecast to post earnings per share of €0.13 next year compared to a net loss per share of €0.049 last year.Valuation Update With 7 Day Price Move • Oct 08Investor sentiment improved over the past weekAfter last week's 20% share price gain to €19.06, the stock trades at a forward P/E ratio of 58x. Average forward P/E is 10x in the Chemicals industry in Germany. Total returns to shareholders of 14% over the past three years.Valuation Update With 7 Day Price Move • Sep 17Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to €17.56, the stock trades at a forward P/E ratio of 54x. Average forward P/E is 9x in the Chemicals industry in Germany. Total returns to shareholders of 5.0% over the past three years.Reported Earnings • Sep 02First half 2022 earnings released: EPS: €0 (vs €0.23 loss in 1H 2021)First half 2022 results: EPS: €0 (up from €0.23 loss in 1H 2021). Revenue: €30.7m (up 53% from 1H 2021). Net income: €491.3k (up €1.60m from 1H 2021). Profit margin: 1.6% (up from net loss in 1H 2021). Over the next year, revenue is forecast to grow 17%, compared to a 2.3% growth forecast for the Chemicals industry in Germany.Reported Earnings • Apr 29Full year 2021 earnings releasedFull year 2021 results: Revenue: €47.6m (up 45% from FY 2020). Net loss: €234.6k (down 123% from profit in FY 2020). Over the next year, revenue is forecast to grow 19%, compared to a 10% growth forecast for the industry in Germany.Price Target Changed • Apr 27Price target increased to €64.50Up from €38.73, the current price target is provided by 1 analyst. New target price is 88% above last closing price of €34.35. Stock is down 17% over the past year. The company is forecast to post earnings per share of €0.16 for next year compared to €0.25 last year.Reported Earnings • Mar 21Full year 2020 earnings releasedThe company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: €42.2m (down 14% from FY 2019). Net income: €1.00m (up 16% from FY 2019). Profit margin: 2.4% (up from 1.8% in FY 2019). The increase in margin was driven by lower expenses.Is New 90 Day High Low • Feb 02New 90-day high: €38.40The company is up 146% from its price of €15.60 on 04 November 2020. The German market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 25% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €121 per share.Price Target Changed • Jan 27Price target raised to €28.07Up from €18.10, the current price target is an average from 3 analysts. The new target price is 20% below the current share price of €35.20. As of last close, the stock is up 135% over the past year.Valuation Update With 7 Day Price Move • Dec 11Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to €29.20, the stock is trading at a trailing P/E ratio of 70.3x, down from the previous P/E ratio of 85.2x. This compares to an average P/E of 26x in the Chemicals industry in Germany. Total returns to shareholders over the past three years are 74%.Valuation Update With 7 Day Price Move • Dec 05Market bids up stock over the past weekAfter last week's 29% share price gain to €35.40, the stock is trading at a trailing P/E ratio of 79.4x, up from the previous P/E ratio of 61.5x. This compares to an average P/E of 27x in the Chemicals industry in Germany. Total returns to shareholders over the past three years are 115%.Valuation Update With 7 Day Price Move • Dec 03Market bids up stock over the past weekAfter last week's 23% share price gain to €35.60, the stock is trading at a trailing P/E ratio of 76.7x, up from the previous P/E ratio of 62.5x. This compares to an average P/E of 27x in the Chemicals industry in Germany. Total returns to shareholders over the past three years are 116%.Valuation Update With 7 Day Price Move • Nov 30Market pulls back on stock over the past weekAfter last week's 16% share price decline to €27.40, the stock is trading at a trailing P/E ratio of 64.4x, down from the previous P/E ratio of 76.6x. This compares to an average P/E of 27x in the Chemicals industry in Germany. Total returns to shareholders over the past three years are 70%.Valuation Update With 7 Day Price Move • Nov 19Market bids up stock over the past weekAfter last week's 18% share price gain to €18.70, the stock is trading at a trailing P/E ratio of 42.7x, up from the previous P/E ratio of 36.3x. This compares to an average P/E of 26x in the Chemicals industry in Germany. Total returns to shareholders over the past three years are 10%.Is New 90 Day High Low • Nov 12New 90-day high: €16.60The company is up 52% from its price of €10.90 on 14 August 2020. The German market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €4.81 per share.Valuation Update With 7 Day Price Move • Nov 02Market bids up stock over the past weekAfter last week's 29% share price gain to €16.50, the stock is trading at a trailing P/E ratio of 32x, up from the previous P/E ratio of 24.8x. This compares to an average P/E of 24x in the Chemicals industry in Germany. Total returns to shareholders over the past three years are 4.0%.Valuation Update With 7 Day Price Move • Oct 22Market bids up stock over the past weekAfter last week's 20% share price gain to €13.30, the stock is trading at a trailing P/E ratio of 30.4x, up from the previous P/E ratio of 25.3x. This compares to an average P/E of 31x in the Chemicals industry in Germany. Total return to shareholders over the past three years is a loss of 19%.Valuation Update With 7 Day Price Move • Oct 19Market bids up stock over the past weekAfter last week's 16% share price gain to €13.40, the stock is trading at a trailing P/E ratio of 30.1x, up from the previous P/E ratio of 26.1x. This compares to an average P/E of 26x in the Chemicals industry in Germany. Total return to shareholders over the past three years is a loss of 16%.Is New 90 Day High Low • Oct 19New 90-day high: €13.40The company is up 19% from its price of €11.30 on 21 July 2020. The German market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €5.88 per share.이익 및 매출 성장 예측DB:IBU - 애널리스트 향후 추정치 및 과거 재무 데이터 (EUR Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/2028722312112/31/2027571328112/31/202637-2-313112/31/2025460514N/A9/30/202546-1411N/A6/30/202546-338N/A3/31/202549-439N/A12/31/202452-529N/A9/30/202451-618N/A6/30/202449-606N/A3/31/202449-4-34N/A12/31/202349-2-52N/A9/30/202350-1-91N/A6/30/2023501-130N/A3/31/2023521-13-2N/A12/31/2022541-13-3N/A9/30/2022541N/AN/AN/A6/30/2022541-10-5N/A3/31/2022491-8-3N/A12/31/2021450-6-1N/A9/30/202142-1N/AN/AN/A6/30/202139-2-6-3N/A3/31/2021360-31N/A12/31/202033114N/A9/30/2020341N/AN/AN/A6/30/2020352510N/A3/31/202042127N/A12/31/2019491-24N/A9/30/2019572N/AN/AN/A6/30/2019512N/A2N/A3/31/2019422N/A3N/A12/31/2018332N/A3N/A9/30/2018180N/A3N/A6/30/201817-1N/A2N/A3/31/2018170N/A2N/A12/31/2017170N/A1N/A9/30/2017182N/A1N/A6/30/2017183N/A2N/A3/31/2017183N/A3N/A12/31/2016183N/A4N/A12/31/2015173N/A4N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: IBU 의 연간 예상 수익 증가율(74.5%)이 saving rate(1.9%)보다 높습니다.수익 vs 시장: IBU 의 연간 수익(74.5%)이 German 시장(17.1%)보다 빠르게 성장할 것으로 예상됩니다.고성장 수익: IBU 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.수익 대 시장: IBU 의 수익(연간 26.5%)이 German 시장(연간 6.8%)보다 빠르게 성장할 것으로 예상됩니다.고성장 매출: IBU 의 수익(연간 26.5%)은 연간 20%보다 빠르게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: IBU의 자본 수익률은 3년 후 4.7%로 낮을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YMaterials 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/22 17:43종가2026/05/22 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스IBU-tec advanced materials AG는 2명의 분석가가 다루고 있습니다. 이 중 1명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Patrick SpeckMontega AGOliver SchwarzWarburg Research GmbH
Price Target Changed • May 20Price target increased by 238% to €25.00Up from €7.40, the current price target is provided by 1 analyst. New target price is 60% above last closing price of €15.65. Stock is up 123% over the past year. The company is forecast to post a net loss per share of €0.44 compared to earnings per share of €0.0012 last year.
공시 • Apr 16Ibu-Tec Advanced Materials Ag Provides Revenue Guidance for 2025Ibu-Tec Advanced Materials Ag provided Revenue Guidance for 2025. For the period, the company expected revenue EUR 43 million to EUR 45 million after consolidated revenues of around EUR 50.6 million in the past financial year according to preliminary unaudited figures.
Price Target Changed • Dec 30Price target decreased by 38% to €7.40Down from €12.00, the current price target is provided by 1 analyst. New target price is 13% above last closing price of €6.52. Stock is down 64% over the past year. The company posted a net loss per share of €0.52 last year.
Price Target Changed • Nov 16Price target decreased to €58.00Down from €64.50, the current price target is provided by 1 analyst. New target price is 119% above last closing price of €26.50. Stock is down 38% over the past year. The company is forecast to post earnings per share of €0.13 next year compared to a net loss per share of €0.049 last year.
Price Target Changed • Apr 27Price target increased to €64.50Up from €38.73, the current price target is provided by 1 analyst. New target price is 88% above last closing price of €34.35. Stock is down 17% over the past year. The company is forecast to post earnings per share of €0.16 for next year compared to €0.25 last year.
Price Target Changed • Jan 27Price target raised to €28.07Up from €18.10, the current price target is an average from 3 analysts. The new target price is 20% below the current share price of €35.20. As of last close, the stock is up 135% over the past year.
Price Target Changed • May 20Price target increased by 238% to €25.00Up from €7.40, the current price target is provided by 1 analyst. New target price is 60% above last closing price of €15.65. Stock is up 123% over the past year. The company is forecast to post a net loss per share of €0.44 compared to earnings per share of €0.0012 last year.
공시 • Apr 09+ 1 more updateIBU-tec advanced materials AG announces Annual dividend, payable on May 22, 2026IBU-tec advanced materials AG announced Annual dividend of EUR 0.1200 per share payable on May 22, 2026, ex-date on May 20, 2026 and record date on May 21, 2026.
공시 • Mar 30+ 1 more updateIBU-tec advanced materials AG to Report Fiscal Year 2025 Results on Apr 08, 2026IBU-tec advanced materials AG announced that they will report fiscal year 2025 results at 12:00 PM, Central European Standard Time on Apr 08, 2026
공시 • Jun 24IBU-tec advanced materials AG to Report First Half, 2025 Results on Aug 27, 2025IBU-tec advanced materials AG announced that they will report first half, 2025 results on Aug 27, 2025
공시 • Apr 17IBU-tec advanced materials AG, Annual General Meeting, May 26, 2025IBU-tec advanced materials AG, Annual General Meeting, May 26, 2025, at 10:00 W. Europe Standard Time.
공시 • Apr 16Ibu-Tec Advanced Materials Ag Provides Revenue Guidance for 2025Ibu-Tec Advanced Materials Ag provided Revenue Guidance for 2025. For the period, the company expected revenue EUR 43 million to EUR 45 million after consolidated revenues of around EUR 50.6 million in the past financial year according to preliminary unaudited figures.
공시 • Jan 08IBU-tec advanced materials AG to Report Fiscal Year 2024 Results on Mar 20, 2025IBU-tec advanced materials AG announced that they will report fiscal year 2024 results at 12:00 PM, Central European Standard Time on Mar 20, 2025
Price Target Changed • Dec 30Price target decreased by 38% to €7.40Down from €12.00, the current price target is provided by 1 analyst. New target price is 13% above last closing price of €6.52. Stock is down 64% over the past year. The company posted a net loss per share of €0.52 last year.
Reported Earnings • Sep 01First half 2024 earnings released: €0.66 loss per share (vs €0.078 profit in 1H 2023)First half 2024 results: €0.66 loss per share (down from €0.078 profit in 1H 2023). Revenue: €25.3m (down 1.1% from 1H 2023). Net loss: €3.15m (down €3.53m from profit in 1H 2023). Revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 25 percentage points per year, which is a significant difference in performance.
공시 • Aug 29IBU-tec advanced materials AG to Report First Half, 2024 Results on Aug 27, 2024IBU-tec advanced materials AG announced that they will report first half, 2024 results on Aug 27, 2024
공시 • Mar 22IBU-tec advanced materials AG, Annual General Meeting, Apr 30, 2024IBU-tec advanced materials AG, Annual General Meeting, Apr 30, 2024.
Valuation Update With 7 Day Price Move • Mar 22Investor sentiment improves as stock rises 22%After last week's 22% share price gain to €11.46, the stock trades at a trailing P/E ratio of 51.8x. Average forward P/E is 18x in the Chemicals industry in Germany. Total loss to shareholders of 74% over the past three years.
공시 • Mar 21IBU-tec advanced materials AG to Report Fiscal Year 2023 Results on Mar 21, 2024IBU-tec advanced materials AG announced that they will report fiscal year 2023 results on Mar 21, 2024
New Risk • Mar 12New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (15% average weekly change). High level of non-cash earnings (22% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Market cap is less than US$100m (€47.5m market cap, or US$51.9m).
Valuation Update With 7 Day Price Move • Jan 29Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €15.98, the stock trades at a trailing P/E ratio of 65.2x. Average forward P/E is 13x in the Chemicals industry in Germany. Total loss to shareholders of 56% over the past three years.
Valuation Update With 7 Day Price Move • Jan 13Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to €13.68, the stock trades at a trailing P/E ratio of 56.9x. Average forward P/E is 13x in the Chemicals industry in Germany. Total loss to shareholders of 44% over the past three years.
New Risk • Dec 09New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €90.7m (US$97.7m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (14% average weekly change). High level of non-cash earnings (22% accrual ratio). Minor Risk Market cap is less than US$100m (€90.7m market cap, or US$97.7m).
Valuation Update With 7 Day Price Move • Oct 20Investor sentiment deteriorates as stock falls 21%After last week's 21% share price decline to €18.00, the stock trades at a forward P/E ratio of 62x. Average forward P/E is 15x in the Chemicals industry in Germany. Total returns to shareholders of 42% over the past three years.
Reported Earnings • Aug 30First half 2023 earnings released: EPS: €0.078 (vs €0.10 in 1H 2022)First half 2023 results: EPS: €0.078 (down from €0.10 in 1H 2022). Revenue: €25.5m (down 14% from 1H 2022). Net income: €372.8k (down 24% from 1H 2022). Profit margin: 1.5% (down from 1.7% in 1H 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 30% p.a. on average during the next 3 years, compared to a 2.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 28% per year, which means it is tracking significantly ahead of earnings growth.
New Risk • Aug 28New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 22% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (22% accrual ratio). Minor Risk Share price has been volatile over the past 3 months (8.0% average weekly change).
Upcoming Dividend • Apr 20Upcoming dividend of €0.04 per share at 0.1% yieldEligible shareholders must have bought the stock before 27 April 2023. Payment date: 02 May 2023. Trailing yield: 0.1%. Lower than top quartile of German dividend payers (4.7%). Lower than average of industry peers (5.3%).
Reported Earnings • Mar 27Full year 2022 earnings releasedFull year 2022 results: Revenue: €56.0m (up 26% from FY 2021). Net income: €1.28m (up €1.52m from FY 2021). Profit margin: 2.3% (up from net loss in FY 2021). The move to profitability was driven by higher revenue. Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 1.9% growth forecast for the Chemicals industry in Germany.
Price Target Changed • Nov 16Price target decreased to €58.00Down from €64.50, the current price target is provided by 1 analyst. New target price is 119% above last closing price of €26.50. Stock is down 38% over the past year. The company is forecast to post earnings per share of €0.13 next year compared to a net loss per share of €0.049 last year.
Valuation Update With 7 Day Price Move • Oct 08Investor sentiment improved over the past weekAfter last week's 20% share price gain to €19.06, the stock trades at a forward P/E ratio of 58x. Average forward P/E is 10x in the Chemicals industry in Germany. Total returns to shareholders of 14% over the past three years.
Valuation Update With 7 Day Price Move • Sep 17Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to €17.56, the stock trades at a forward P/E ratio of 54x. Average forward P/E is 9x in the Chemicals industry in Germany. Total returns to shareholders of 5.0% over the past three years.
Reported Earnings • Sep 02First half 2022 earnings released: EPS: €0 (vs €0.23 loss in 1H 2021)First half 2022 results: EPS: €0 (up from €0.23 loss in 1H 2021). Revenue: €30.7m (up 53% from 1H 2021). Net income: €491.3k (up €1.60m from 1H 2021). Profit margin: 1.6% (up from net loss in 1H 2021). Over the next year, revenue is forecast to grow 17%, compared to a 2.3% growth forecast for the Chemicals industry in Germany.
Reported Earnings • Apr 29Full year 2021 earnings releasedFull year 2021 results: Revenue: €47.6m (up 45% from FY 2020). Net loss: €234.6k (down 123% from profit in FY 2020). Over the next year, revenue is forecast to grow 19%, compared to a 10% growth forecast for the industry in Germany.
Price Target Changed • Apr 27Price target increased to €64.50Up from €38.73, the current price target is provided by 1 analyst. New target price is 88% above last closing price of €34.35. Stock is down 17% over the past year. The company is forecast to post earnings per share of €0.16 for next year compared to €0.25 last year.
Reported Earnings • Mar 21Full year 2020 earnings releasedThe company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: €42.2m (down 14% from FY 2019). Net income: €1.00m (up 16% from FY 2019). Profit margin: 2.4% (up from 1.8% in FY 2019). The increase in margin was driven by lower expenses.
Is New 90 Day High Low • Feb 02New 90-day high: €38.40The company is up 146% from its price of €15.60 on 04 November 2020. The German market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 25% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €121 per share.
Price Target Changed • Jan 27Price target raised to €28.07Up from €18.10, the current price target is an average from 3 analysts. The new target price is 20% below the current share price of €35.20. As of last close, the stock is up 135% over the past year.
Valuation Update With 7 Day Price Move • Dec 11Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to €29.20, the stock is trading at a trailing P/E ratio of 70.3x, down from the previous P/E ratio of 85.2x. This compares to an average P/E of 26x in the Chemicals industry in Germany. Total returns to shareholders over the past three years are 74%.
Valuation Update With 7 Day Price Move • Dec 05Market bids up stock over the past weekAfter last week's 29% share price gain to €35.40, the stock is trading at a trailing P/E ratio of 79.4x, up from the previous P/E ratio of 61.5x. This compares to an average P/E of 27x in the Chemicals industry in Germany. Total returns to shareholders over the past three years are 115%.
Valuation Update With 7 Day Price Move • Dec 03Market bids up stock over the past weekAfter last week's 23% share price gain to €35.60, the stock is trading at a trailing P/E ratio of 76.7x, up from the previous P/E ratio of 62.5x. This compares to an average P/E of 27x in the Chemicals industry in Germany. Total returns to shareholders over the past three years are 116%.
Valuation Update With 7 Day Price Move • Nov 30Market pulls back on stock over the past weekAfter last week's 16% share price decline to €27.40, the stock is trading at a trailing P/E ratio of 64.4x, down from the previous P/E ratio of 76.6x. This compares to an average P/E of 27x in the Chemicals industry in Germany. Total returns to shareholders over the past three years are 70%.
Valuation Update With 7 Day Price Move • Nov 19Market bids up stock over the past weekAfter last week's 18% share price gain to €18.70, the stock is trading at a trailing P/E ratio of 42.7x, up from the previous P/E ratio of 36.3x. This compares to an average P/E of 26x in the Chemicals industry in Germany. Total returns to shareholders over the past three years are 10%.
Is New 90 Day High Low • Nov 12New 90-day high: €16.60The company is up 52% from its price of €10.90 on 14 August 2020. The German market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €4.81 per share.
Valuation Update With 7 Day Price Move • Nov 02Market bids up stock over the past weekAfter last week's 29% share price gain to €16.50, the stock is trading at a trailing P/E ratio of 32x, up from the previous P/E ratio of 24.8x. This compares to an average P/E of 24x in the Chemicals industry in Germany. Total returns to shareholders over the past three years are 4.0%.
Valuation Update With 7 Day Price Move • Oct 22Market bids up stock over the past weekAfter last week's 20% share price gain to €13.30, the stock is trading at a trailing P/E ratio of 30.4x, up from the previous P/E ratio of 25.3x. This compares to an average P/E of 31x in the Chemicals industry in Germany. Total return to shareholders over the past three years is a loss of 19%.
Valuation Update With 7 Day Price Move • Oct 19Market bids up stock over the past weekAfter last week's 16% share price gain to €13.40, the stock is trading at a trailing P/E ratio of 30.1x, up from the previous P/E ratio of 26.1x. This compares to an average P/E of 26x in the Chemicals industry in Germany. Total return to shareholders over the past three years is a loss of 16%.
Is New 90 Day High Low • Oct 19New 90-day high: €13.40The company is up 19% from its price of €11.30 on 21 July 2020. The German market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €5.88 per share.